CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
69.42
-0.39 (-0.56%)
Apr 8, 2026, 1:09 PM EDT - Market open
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $5.86 billion as of April 8, 2026. Its market cap has increased by 184.63% in one year.
Market Cap
5.86B
Enterprise Value
5.16B
1-Year Change
184.63%
Ranking
Category
Stock Price
$69.42
Market Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $5.86B, an increase of 385.96%. That is a compound annual growth rate of 105.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 5.89B | 75.99% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Centessa Pharmaceuticals | 6.14B |
| Terns Pharmaceuticals | 6.09B |
| Rhythm Pharmaceuticals | 5.94B |
| Mirum Pharmaceuticals | 5.81B |
| Cogent Biosciences | 5.70B |
| PTC Therapeutics | 5.70B |
| Scholar Rock Holding | 5.61B |
| Celcuity | 5.52B |